Patients with Lambert-Eaton myasthenic syndrome (LEMS) and their families face a variety of challenges every day. The cost of treatment should NOT be one of them. That’s why we created Catalyst Pathways®—a free program that offers personalized support and assistance to adults with LEMS and their families.
The My FIRDAPSE Therapeutic Dose Program is designed to help you and your doctor determine the FIRDAPSE dose that will safely provide optimal relief of your LEMS symptoms while minimizing medication side effects.
After your doctor establishes your starting dose, he or she will work with you to adjust your dose gradually over the next week or two. Typically, the dose is increased every 3 or 4 days until optimal relief is achieved. This process is known as titration.
The My FIRDAPSE Therapeutic Dose Program provides support throughout the titration process, including:
Complete the Enrollment Form with your doctor or call 1-833-4-CATALYST
(1-833-422-8259) for assistance.
Go to YourCatalystPathways.com for a full list of the support programs available, including financial assistance.
While your insurance coverage is being reviewed, Catalyst Pathways will provide qualifying patients with “Bridge” medicine (free medicine to carry eligible patients over the gap between insurance investigation and confirmation of coverage).*
Call 1-833-422-8259 to learn if you qualify for this program.
Available for new adult patients with LEMS who are enrolled in the Catalyst Pathways program, are not currently on amifampridine (3,4-DAP), and have been prescribed FIRDAPSE. Some restrictions apply.
For patients with commercial insurance, Catalyst Pathways lowers out-of-pocket costs to $0/month.
If you do not have insurance or are denied coverage, Catalyst Pathways provides free medicine to qualifying patients for as long as it’s needed.
If you’re having trouble paying your out-of-pocket costs, Catalyst Pathways can direct you to nonprofit organizations that can help you pay for your medicine.
patients have been prescribed FIRDAPSE
amifampridine-naïve patients gained their first access to therapy
of qualifying patients pay nothing OOP for their prescription
Average monthly copay for patients enrolled in Catalyst Pathways*
*Includes those who are covered by Medicare and accessing Foundation Assistance. Individual costs may vary. Average copay cost represents the latest 2021 data on file and excludes patients who did not elect to pursue Foundation Assistance.
Assures delivery of FIRDAPSE no matter what
Catalyst Pharmaceuticals understands that FIRDAPSE can only help patients if they have the therapy. Through the FIRDAPSE Delivery Assurance Program, they will. Program team members are constantly monitoring and anticipating potential obstacles to delivery and are formulating alternate plans to ensure that patients can always get their tablets. Whatever the threat—hurricane, tornado, earthquake, transit strike, or major sporting event—Catalyst is ready to deliver.
FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.
What is the most important information I should know about FIRDAPSE?
Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.
Do not take FIRDAPSE if you:
Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How should I take FIRDAPSE?
What are the possible side effects of FIRDAPSE?
FIRDAPSE may cause serious side effects, including:
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of FIRDAPSE.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store FIRDAPSE?
Keep FIRDAPSE and all medicines out of the reach of children.
If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.
The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.
Please see full Prescribing Information for additional Important Safety Information.
FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.
What is the most important information I should know about FIRDAPSE?
Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.
Do not take FIRDAPSE if you:
Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How should I take FIRDAPSE?
What are the possible side effects of FIRDAPSE?
FIRDAPSE may cause serious side effects, including:
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of FIRDAPSE.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store FIRDAPSE?
Keep FIRDAPSE and all medicines out of the reach of children.
If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.
The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.
Please see full Prescribing Information for additional Important Safety Information.
